Gioia, Gerard A.
- University of California, Los Angeles · Pediatrics (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #46,067
- Rising Star
- Program Leader
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2014 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pediatrics
NIH Funding · FY2023
Linked Award Amount
$61.8K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#46,067
By linked amount among FY2023 PIs
Earliest Year Loaded
2014
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Gioia, Gerard A. as a PI. Multi-PI records show the full award amount for context.
- 3U54NS121688-02S1U54Contact PIEndophenotypes of Persistent Post-Concussive Symptoms in Adolescents: CARE4KidsUniversity of California, Los Angeles · Pediatrics (NIH department code)$61.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Gioia, Gerard A. as a PI.
FY2023 award administered by University of California, Los Angeles (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2014First NIH AwardUniversity of California, Los Angeles
- 2014$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2016$2M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #5972
- 2018Program/Center Grant Leader
- 2021$5M Cumulative Funding
- 2021Entered Top 25% NationallyRanked #1403
- 2021Entered Top 10% NationallyRanked #1403
- 2022$10M Cumulative Funding